Novo Nordisk’s Amycretin Pill: A Game-Changing Oral Option for Double Duty on Weight Loss and Diabetes Control
Novo Nordiskโs new amycretin pill achieves up to 14.5% weight loss and excellent blood sugar control in type 2 diabetes, a once-daily oral game-changer vs Ozempic injections.
Read More